CRIS Current Research Information System

MANERBA, MARCELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.096
EU - Europa 1.280
AS - Asia 1.196
AF - Africa 152
SA - Sud America 96
OC - Oceania 7
Totale 4.827
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.086
CN - Cina 390
SG - Singapore 369
IT - Italia 282
GB - Regno Unito 277
VN - Vietnam 166
DE - Germania 146
SE - Svezia 109
HK - Hong Kong 102
IN - India 81
BR - Brasile 75
CH - Svizzera 66
RU - Federazione Russa 66
UA - Ucraina 58
FR - Francia 57
IE - Irlanda 56
TG - Togo 52
CI - Costa d'Avorio 42
NL - Olanda 40
BG - Bulgaria 27
FI - Finlandia 25
NG - Nigeria 24
ZA - Sudafrica 23
KR - Corea 21
EE - Estonia 19
JO - Giordania 19
JP - Giappone 19
BE - Belgio 16
AT - Austria 11
ID - Indonesia 11
AR - Argentina 10
ES - Italia 7
AU - Australia 6
SC - Seychelles 6
CA - Canada 5
PL - Polonia 5
IQ - Iraq 4
MX - Messico 4
CO - Colombia 3
LT - Lituania 3
PY - Paraguay 3
SA - Arabia Saudita 3
BD - Bangladesh 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
LB - Libano 2
MA - Marocco 2
PK - Pakistan 2
RO - Romania 2
RS - Serbia 2
TW - Taiwan 2
BH - Bahrain 1
CL - Cile 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
HR - Croazia 1
MD - Moldavia 1
MU - Mauritius 1
MW - Malawi 1
NC - Nuova Caledonia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
TR - Turchia 1
UY - Uruguay 1
Totale 4.827
Salva come PNG Salva come JPEG
Città #
Ashburn 294
Singapore 266
Fairfield 246
Southend 244
Chandler 209
Woodbridge 138
Bologna 122
Houston 105
Hong Kong 101
Seattle 99
Santa Clara 98
Wilmington 93
Ann Arbor 80
Cambridge 75
Dong Ket 75
Bern 64
Princeton 57
Dublin 56
Hefei 56
Lomé 52
Beijing 51
Abidjan 42
Redmond 40
Boardman 36
Jacksonville 31
New York 30
Sofia 27
Nanjing 26
Los Angeles 25
Abeokuta 24
Westminster 23
Ho Chi Minh City 22
Hanoi 21
Seoul 21
Padova 20
Shenyang 20
Buffalo 19
Amman 18
Berlin 17
Helsinki 17
San Diego 17
Tokyo 16
Brussels 15
Milan 13
Guangzhou 12
Jalandhar 12
Turin 12
Frankfurt am Main 11
Saint Petersburg 11
Tianjin 10
Falls Church 9
Jinan 9
Shanghai 9
Yubileyny 9
Amsterdam 8
Changsha 8
Des Moines 8
Falkenstein 8
Mülheim 8
Bremen 7
Florence 7
Haikou 7
Jakarta 7
Nanchang 7
Nuremberg 7
Belo Horizonte 6
Dallas 6
Düsseldorf 6
Hebei 6
Redondo Beach 6
Rome 6
São Paulo 6
Turku 6
Hangzhou 5
Lauterbourg 5
London 5
Mahé 5
Paris 5
Redwood City 5
Bengaluru 4
Brooklyn 4
Bühl 4
Chennai 4
Dearborn 4
Genova 4
Haiphong 4
Jiaxing 4
Lucca 4
Phoenix 4
Portsmouth 4
Pune 4
San Venanzo 4
Taiyuan 4
Warsaw 4
Baghdad 3
Castel Maggiore 3
Edinburgh 3
Genoa 3
Melbourne 3
Munich 3
Totale 3.463
Salva come PNG Salva come JPEG
Nome #
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells 237
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib 235
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 207
Altered glycosylation profile of purified plasma ACT from Alzheimer's disease. 205
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors. 194
The activation of lactate dehydrogenase induced by mTOR drives neoplastic change in breast epithelial cells 185
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. 183
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. 182
Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells 179
Effect of copper on extracellular levels of key pro-inflammatory molecules in hypothalamic GN11 and primary neurons. 174
LDH inhibition impacts on heat shock response and induces senescence of hepatocellular carcinoma cells 174
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. 173
Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. 168
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors 166
Lactate dehydrogenase inhibition affects homologous recombination repair independently of cell metabolic asset; implications for anticancer treatment 166
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. 164
Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A 157
Albumin-drug conjugates in the treatment of hepatic disorders. 143
The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow. 141
Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulationin Burkitt lymphoma cells via NAD/NADH-dependent inhibition of sirtuin-1 140
Metabolic activation triggered by cAMP in MCF-7 cells generates lethal vulnerability to combined oxamate/etomoxir 139
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination 133
Dihydroquinoline pyrazoline-based compound as a new RAD51-BRCA2 protein-protein disruptor to trigger synthetic lethality in pancreatic cancer 120
Lactate Upregulates the Expression of DNA Repair Genes, Causing Intrinsic Resistance of Cancer Cells to Cisplatin 112
NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases 106
null 101
Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors 101
Lactate dehydrogenase inhibition: Exploring possible applications beyond cancer treatment 89
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy 85
null 78
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy 75
null 71
RAD51 nuclear recruitment and inhibition towards innovative strategies against pancreatic cancer 60
null 51
Design and synthesis of RAD51-BRCA2 disruptors to inhibit homologous recombination and synergize with Olaparib as new anticancer drug discovery concept 31
Totale 4.925
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.701
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021330 0 0 0 0 0 58 15 18 72 31 22 114
2021/2022579 49 10 45 44 48 28 27 53 29 37 116 93
2022/2023817 61 125 26 107 78 54 28 34 134 26 37 107
2023/2024202 13 31 9 25 10 66 8 4 4 15 2 15
2024/2025780 44 75 62 76 135 34 52 39 20 71 37 135
2025/2026873 171 173 134 180 192 23 0 0 0 0 0 0
Totale 4.925